Clinical Trials on Protein-carbohydrates Supplementation in Taiwan

Total 213 results

Cardinal Tien Hospital

Completed

The Impact of Exercise Intervention on Physical Function Falls, and Physical Restraint for Long-term Care Residents

Protein Supplementation | Exercise Intervention

Taiwan
National Taiwan Sport University

Completed

Carbohydrate Rinsing and Caffeine Gum on Performance of Romanian Deadlifts Performance

Caffeine | Carbohydrate

Taiwan
National Cheng-Kung University Hospital
National Science Council, Taiwan

Completed

The Therapeutic Role of Intravenous Albumin Administration for Peptic Ulcer Bleeding Patients With Hypoalbuminemia

Hypoalbuminemia | Peptic Ulcer Bleeding

Taiwan
An Hsin QingShui Clinic

Completed

Dialysis Model for Outcome and Nutrition Decision (DIAMOND)

Protein-Calorie Malnutrition

Taiwan
Taipei Medical University
TCI Co., Ltd.

Recruiting

Effects of Bacillus Coagulans on Liver and Gut Microbiota Function in NAFLD

Effects of Bacillus Coagulans TCI711 Supplementation on Liver and Gut Microbiota Function in Non-alcoholic Fatty Liver Disease Patients

Taiwan
Johnson & Johnson Taiwan Ltd

Completed

A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma

Multiple Myeloma

Taiwan
Chung Shan Medical University

Not yet recruiting

Pharmacokinetic Effect of AstraGin on Whey Protein Absorption and Muscle Function in Healthy Subjects

Pharmacokinetic Effect of AstraGin on Whey Protein Absorption and Muscle Function in Healthy Subjects

Taiwan
Chang Gung Memorial Hospital

Recruiting

High Protein, Core Muscle Rehab, Muscular Electrostimulation in Prolonged Mechanical Ventilation

Prolonged Mechanical Ventilation | Protein Deficiency

Taiwan
National Taiwan University Hospital
National Health Research Institutes, Taiwan

Recruiting

Cancer Fusion Hybrids and Desmoplasia

Bone Marrow Cells | Fusion Protein Expression

Taiwan
Mackay Memorial Hospital
Sanofi Taiwan Co. Ltd

Recruiting

The Intensively Follow-up Examinations for Asymptomatic MPS I Infants in Taiwan

MPS I

Taiwan
Taipei Medical University Shuang Ho Hospital

Completed

Tamoxifen Treatment in Patients With Motor Neuron Disease

Amyotrophic Lateral Sclerosis | ALS Functional Ration Scale | TAR-DNA-binding Protein-43 | Tamoxifen | mTOR

Taiwan
Taipei Veterans General Hospital, Taiwan

Unknown

Effect of Motor Development, Motor Function and Electrophysiologic Findings of IOPD Under ERT

Glycogen Storage Disease Type II

Taiwan
National Taiwan University Hospital

Unknown

Immune Modulation Therapy for Pompe Disease

Pompe Disease

Taiwan
National Taiwan University Hospital

Unknown

CPAP for Infantile Pompe Disease

Pompe Disease

Taiwan
National Taiwan University Hospital

Unknown

A Long Term Follow up Study in Late-onset Pompe Disease

Pompe Disease

Taiwan
National Taiwan University Hospital

Recruiting

High Risk Screen of Childhood Late-onset Pompe Disease in Pediatric Outpatient Clinics

Pompe Disease

Taiwan
National Taiwan University Hospital

Recruiting

A Long-term Study for the Outcome of Pompe Disease

Pompe Disease

Taiwan
National Taiwan University Hospital

Completed

Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease

Pompe Disease

Taiwan
National Taiwan University Hospital

Unknown

Muscle Response to Enzyme Replacement Therapy in Pompe Disease

Pompe Disease

Taiwan
National Taiwan University Hospital

Completed

Newborn Screening Assay of Pompe's Disease

Pompe Disease

Taiwan
Far Eastern Memorial Hospital
Gynecologic Oncology Group

Recruiting

The Association of G9a Protein and Clinical Outcome of Patients With Vulvar Cancer

Vulvar Cancer, G9a Protein

Taiwan
National Taiwan University Hospital

Recruiting

The Natural History of Sialidosis Type I

Observational Study

Taiwan
Sanofi

Recruiting

A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab

Hemophilia A

Taiwan
Celgene

Completed

A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan

Multiple Myeloma

Taiwan
Taipei Medical University Hospital
Sanofi

Enrolling by invitation

Observational Study of Long-Term Joint Health Outcome in Hemophilia Patient

Hemophilia | Arthropathy

Taiwan
National Taiwan University Hospital

Unknown

The Effectiveness of Recombinant Coagulation Factor IX With Recombinant Albumin (rIX-FP) in Severe Hemophilia B Patients

Hemophilia

Taiwan
National Taiwan University Hospital

Unknown

Clinical Implication of Bone Marrow Perfusion Patterns Imaged by Dynamic MRI in Multiple Myeloma

Multiple Myeloma, Newly Diagnosed

Taiwan
Bayer

Completed

EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan

Hemophilia A

Taiwan
National Taiwan University Hospital

Unknown

Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis

Tuberculosis | Monoclonal Gammopathy

Taiwan
Tri-Service General Hospital

Completed

PET Imaging of Hemophilic Arthropathy

Inflammation | Hemophilia | Arthropathy

Taiwan
Chang Gung Memorial Hospital

Completed

C11-Acetate PET/CT in Multiple Myeloma: Added Value to F18-Fluorodeoxyglucose PET/CT (ACTMM)

Multiple Myeloma

Taiwan
National Taiwan University Hospital

Unknown

Study of Risk Factors and Genetic Association With Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma

Multiple Myeloma

Taiwan
Tri-Service General Hospital

Recruiting

A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A)

Severe Hemophilia A Without Inhibitor

Taiwan
Takeda

Recruiting

A Study of Ninlaro in Real World Clinical Practice in China

Multiple Myeloma | Neoplasms, Plasma Cell

China
Genzyme, a Sanofi Company

Completed

Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602

Glycogen Storage Disease Type II

United States, France, Germany, Israel, Italy, Netherlands, Taiwan
LMU Klinikum
Genzyme, a Sanofi Company

Completed

Long-term Outcome in Late-onset Pompe Disease Treated Beyond 36 Months (STIG-Pompe-Study) (STIG)

Pompe Disease

Germany, Taiwan, Italy
Novartis Pharmaceuticals

Completed

PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer

Stomach Neoplasms Esophageal Neoplasms Metastatic Gastric Cancer Mutated PI3KCA Protein Overexpressed HER2 Protein

Taiwan, Switzerland, Korea, Republic of, Germany, United States, Japan
Tri-Service General Hospital

Completed

Sarcopenia and Osteoporosis in the Patients With Hemophilia

Hemophilia | Sarcopenia | Hemophilic Arthropathy | Osteoporosis, Osteopenia

Taiwan
National Taiwan University Hospital

Unknown

High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment

Bleeding | Peptic Ulcer | Endoscopy | Proton Pump Inhibitors

Taiwan
Tsung-Ying Li

Recruiting

Vitamin D Deficiency and Body Composition in the Patients With Hemophilia

Hemophilia | Vitamin D Deficiency | Body Composition | Sarcopenia | Osteoporosis | Hemophilic Arthropathy

Taiwan
Amicus Therapeutics

Available

Expanded Access for ATB200/AT2221 for the Treatment of IOPD

Pompe Disease Infantile-Onset

Taiwan, United States, Italy
GPCR Therapeutics, Inc.

Completed

Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients

Multiple Myeloma | Hodgkin Disease | Non-Hodgkin Lymphoma

Taiwan
Far Eastern Memorial Hospital

Active, not recruiting

Nutritional Interventions in Peritoneal Dialysis Patients With Hypoalbuminemia

End Stage Renal Disease on Dialysis

Taiwan
Kaohsiung Medical University Chung-Ho Memorial...
National Taiwan University Hospital; China Medical University, China; Mackay... and other collaborators

Recruiting

Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment (LONGHEAD)

Diabetes Mellitus | Metabolic Disease | Cryoglobulinemia | HepatoCellular Carcinoma | Liver Fibroses

Taiwan, Korea, Republic of
Bristol-Myers Squibb

Recruiting

A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan

Relapsed or Refractory Multiple Myeloma

Taiwan
Shire
Covance; PRA Health Sciences; PharmaNet

Completed

Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase Therapy

Mucopolysaccharidosis II | Hunter Syndrome | MPS II

Brazil, Poland, Taiwan
Allievex Corporation

Completed

A Treatment Study of Mucopolysaccharidosis Type IIIB (MPS IIIB)

Mucopolysaccharidosis Type IIIB | MPS III B

United States, Taiwan, Spain, Colombia, Germany, United Kingdom, Turkey
National University Hospital, Singapore
Celgene; International Myeloma Foundation; The Australasian Leukaemia & Lymphoma...

Unknown

Carfilzomib Thalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Relapsed and/or Refractory Multiple Myeloma

Singapore, Hong Kong, Korea, Republic of, Taiwan
BioMarin Pharmaceutical

Completed

Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome)

Morquio A Syndrome | MPS IVA | Mucopolysaccharidosis IVA

Taiwan, United States, Italy, United Kingdom
Allievex Corporation

Active, not recruiting

A Treatment Extension Study of Mucopolysaccharidosis Type IIIB

Mucopolysaccharidosis Type IIIB | MPS III B

Germany, United States, Turkey, United Kingdom, Colombia, Spain, Taiwan

Clinical Trials on Protein-carbohydrates Supplementation in Taiwan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations